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Many eukaryotic proteins are attached to the cell
surface via glycosylphosphatidylinositol (GPI) an-
chors. How GPI-anchored proteins (GPI-APs) are
trafficked from the endoplasmic reticulum (ER) to
the cell surface is poorly understood, but the GPI
moiety has been postulated to function as a signal
for sorting and transport. Here, we established
mutant cells that were selectively defective in trans-
port of GPI-APs from the ER to the Golgi. We identi-
fied a responsible gene, designated PGAP5 (post-
GPI-attachment to proteins 5). PGAP5 belongs to
a dimetal-containing phosphoesterase family and
catalyzed the remodeling of the glycan moiety on
GPI-APs. PGAP5 catalytic activity is a prerequisite
for the efficient exit of GPI-APs from the ER. Our
data demonstrate that GPI glycan acts as an ER-
exit signal and suggest that glycan remodeling medi-
ated by PGAP5 regulates GPI-AP transport in the
early secretory pathway.
INTRODUCTION
Protein modification by glycosylphosphatidylinositol (GPI)
anchors is a highly conserved posttranslational modification in
eukaryotes (Ferguson et al., 2008). Approximately 150 proteins
are modified by GPI, which is vital for embryonic development,
immune responses, and neurogenesis in mammals. GPI biosyn-
thesis and attachment to proteins are carried out on the endo-
plasmic reticulum (ER) membrane. Many genes involved in the
GPI biosynthetic pathway have been characterized in mamma-
lian cells, yeasts, and trypanosomes (Ferguson, 1999; Orlean
and Menon, 2007). However, relatively little is known about how
the modified proteins are targeted to their proper destinations.
In the early secretory pathway, proteins including GPI-
anchored proteins (GPI-APs) are transported from the ER in352 Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc.vesicles formed by coat protein complex II (COPII). Most
proteins are actively sorted and packaged into these vesicles
(Belden and Barlowe, 2001b; Malkus et al., 2002), although
a bulk flow export mechanism also exists. GPI attachment to
proteins is indispensable for their exit from the ER, otherwise
most proteins are degraded by the proteasome through ER-
associated degradation. GPI is an ER export signal in protozoan
parasite Trypanosoma brucei (McDowell et al., 1998). In yeasts,
GPI-APs are sorted and transported from the ER via vesicles that
are distinct from those containing other proteins such as the
general amino acid permease Gap1p and pro-a factors (Muniz
et al., 2001). The p24 family proteins are putative cargo receptors
recycling between the ER and the Golgi, and members of this
family in yeast are required for efficient packaging of GPI-APs
(Muniz et al., 2000; Schimmoller et al., 1995). Inmammalian cells,
efficient transport of GPI-APs also requires p24 family members
(Takida et al., 2008). However, it remains unclear how the p24
family members are involved in the transport of GPI-APs, and
which components and GPI structures actually determine the
exit of GPI-APs from the ER (Kaiser, 2000).
In addition to the early secretory pathways, GPI-APs have
unique properties in other secretory and endocytic pathways.
Many GPI-APs are transported to the apical side of the plasma
membrane in several types of epithelial cells, and to the axonal
regions of neuronal cells (Brown et al., 1989; Lisanti et al.,
1989; Paladino et al., 2006). It has also been reported that
several GPI-APs are selectively internalized by a unique pathway
involving dynamin-independent, Cdc42- and ARF1-regulated
endocytic vesicles (Kumari and Mayor, 2008; Sabharanjak
et al., 2002). The GPI anchor functions as a sorting signal for
selective targeting of GPI-APs to this pathway. The sorting of
GPI-APs to the secretory and endocytic pathways seems to be
correlated with their associations with specialized lipid domains,
designated lipid rafts or nanoclusters (Brown and Rose, 1992;
Goswami et al., 2008; Simons and Ikonen, 1997). Although there
are no satisfactory definitions of these specialized lipid domains,
certain lipids form membrane microdomains that function as
platforms for intracellular signaling or are required for selec-
tive transport of proteins (Mayor and Riezman, 2004). GPI is
synthesized from phosphatidylinositol (PI) containing an unsatu-
rated fatty acid at the sn-2 position, whereas GPI-APs have
a saturated fatty acid at the sn-2 position in mammalian cells
(Figure S1 available online). The lipid moieties of the GPI anchors
are remodeled after GPI attachment to proteins, and this remod-
eling is critical for lipid raft association inmammalian cells as well
as in yeasts (Bosson et al., 2006; Fujita et al., 2006a; Maeda
et al., 2007).
Unlike other lipid membrane anchoring, such as acylation and
prenylation, GPI bears a complex glycan portion between a
protein and its lipid anchor. In contrast to the function of the
GPI lipid moiety, the function of the glycan moiety is not well
understood. There is a structural difference between the glycan
moieties of GPI just before attachment to proteins in the ER and
GPI-APs on the cell surface (Figure S1). In the GPI biosynthetic
pathway, a side-chain ethanolamine-phosphate (EtNP) can be
attached to the second Man (Man2) of the GPI intermediate by
PIG-G/GPI7 and PIG-F, thereby generating the complete pre-
cursor H8 (Hirose et al., 1992; Shishioh et al., 2005). However,
most GPI-APs on the cell surface do not contain this side-chain
EtNP on Man2 of GPI (Ferguson et al., 2008). Therefore, it has
been considered that the GPI structure H7, which lacks a side-
chain EtNP on Man2, may be the major precursor for protein
attachment, and that H8 is a structural variant of H7with a similar
function.
In the present study, we screenedmutants defective in GPI-AP
transport and identified a gene required for processing of the
glycanmoiety onGPI. First, chinese hamster ovary (CHO)mutant
cell lines defective in transport of GPI-APs were established. The
mutant cells exhibited severe transport delay of GPI-APs from
the ER to the Golgi. GPI-APs on the cell surface retained a
side-chain EtNP on Man2 of the GPI glycan in the mutant cells,
whereas this side chain was mostly removed in wild-type (WT)
cells. We identified the gene responsible for the defect of the
mutant cells and designated it PGAP5 (post-GPI attachment to
proteins 5). PGAP5 was a phosphoesterase directly required
for removal of a side-chain EtNP from Man2 of GPI to allow effi-
cient exit of GPI-APs from the ER. Our results suggest that
remodeling of the GPI glycan regulates the transport of GPI-
APs from the ER to the Golgi. To our knowledge, this is the first
report to describe the physiological importance of the glycan
portion of GPI anchors.
RESULTS
Establishment and Characterization
of Mutant Cell Lines
To establish mutant cells defective in GPI-AP transport, FF8 was
used as a parental cell line (Maeda et al., 2008). In the FF8 cell
line, expression of a Flag-tagged temperature-sensitive reporter
protein, VSVGex-Flag-GFP-GPI (VFG-GPI), was induced by add-
ing doxycycline at the nonpermissive temperature of 40C,
thereby causing accumulation in the ER of VFG-GPI, which could
then be released from the ER all at once by shifting the temper-
ature to 32C (Figure S2). Transport of VFG-GPI to the plasma
membrane was monitored by flow cytometry of the surface
expression of the Flag-tag at various times after the tempera-
ture shift. FF8 cells were mutagenized with N-methyl-N’-nitro-N-nitrosoguanidine and several rounds of similar transport
assays were performed to sort out the mutant cells displaying
delayed transport of VFG-GPI. Mutant clones 9 (C9) and 19
(C19) cells were finally obtained (Figure 1A). C9 and C19 mutant
cells exhibited defective transport of the reporter protein (Figures
1B and 1C; data for C9 not shown). Transport of a transmem-
brane protein, Flag-VSVGfull-GFP (FVG-TM), to the cell surface
was barely affected in these mutant cells (Figures 1D and 1E),
indicating that GPI-AP transport was selectively delayed in these
mutant cells.
We investigated whether the mutant cells were defective in
genes known to be involved in GPI biosynthesis and remodeling.
Steady-state surface expression of GPI-APs and GPI biosyn-
thesis were normal (Figures S3A and S3B). We also confirmed
the normal PI-phospholipase C (PLC) sensitivity of GPI-APs
(Figure S3C), indicating that the mutant cells were not defective
in the GPI-inositol deacylase PGAP1 (Tanaka et al., 2004). The
fatty acid remodeling of GPI-APs, which is essential for the asso-
ciation of GPI-APs with lipid rafts (Maeda et al., 2007), was also
normal as assessed by association of GPI-APs with detergent-
resistant membranes (Figure S3D). These results indicate that
themutant cells do not have a defect in the biosynthesis and lipid
remodeling of GPI.
ER-to-Golgi Transport of GPI-APs Is Impaired
in Mutant Cells
Next, we analyzed decay-accelerating factor (DAF), a GPI-AP, in
the mutant cells to determine whether the mutant cells exhibit
defective transport from the ER to the Golgi. Western blotting
analysis of steady-state levels of ER and mature forms of DAF
showed that in WT cells, the ER form (45 kDa) was smoothly
transported to the Golgi where it accepted O-glycans and modi-
fication of the N-glycan to become the mature form (70–75 kDa),
but that the ER form accumulated in the mutant cells (Figure 2A).
Pulse-chase analyses revealed that transport of DAF from the
ER to the Golgi was severely delayed in the mutant cells (Figures
2B and 2C), whereas the ER-to-Golgi transport of VSVG was
normal (Figures S4A and S4B). We further tested GPI-AP-
specific transport delay in C19 mutant cells using VFG-GPI.
Due to the presence of a furin-cleavage site between VSVG
and Flag-GFP parts, the reporter protein becomes smaller in
size after arrival at the trans-Golgi network. As expected,
conversion of the reporter protein from the 85 kDa form to the
30 kDa form was severely delayed in the mutant cells (Figures
2D and 2E). Taken together, these results indcate that the
mutant cells were selectively impaired in the transport of GPI-
APs from the ER to the Golgi.
Expression Cloning of PGAP5, the Gene Responsible
for the Defect in GPI-AP Transport
The gene responsible for the defective transport in C19 cells was
identified by expression cloning based on restored protein trans-
port. A retrovirus cDNA library prepared from human brain was
used for the expression cloning. The identified gene, designated
PGAP5, was previously recorded as metallophosphoesterase 1
(MPPE1; gene accession number NM_023075 for Homo sapi-
ens), but its function was unknown. Human PGAP5 encodes
a membrane protein bearing a phosphoesterase motif on theCell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc. 353
Figure 1. Establishment of Mutant Cells Defective in Transport of GPI-APs
(A) Flow cytometric analysis of reporter proteins. Parental WT FF8 cells andmutant C19 cells expressing VFG-GPI were stainedwith an anti-Flag antibody at 0 and
60 min after a temperature shift from 40C to 32C in a transport assay. The percentages of cells in the R2 region are indicated.
(B–E) The cell-surface expressions of VFG-GPI (B) and FVG-TM (D) were traced by flow cytometry. FF8 (WT) and C19 cells expressing reporter proteins were
stained with an anti-Flag antibody at the indicated times after starting transport. The geometric mean fluorescence values of VFG-GPI (C) and FVG-TM (E) on
all cells shown in histograms were determined at each time point and were plotted. The geometric mean of WT cells at 100 min was plotted as 100% relative
transport.354 Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc.
lumenal side and an ER retrieval signal at the C terminus. Trans-
fection of human and mouse PGAP5 cDNAs restored the de-
layed transport of GPI-APs in both C9 and C19 mutant cells
(Figures 3A and S5A). Accumulation of the ER form of DAF was
also diminished by transfection of human PGAP5 (Figure S5B).
To confirm that PGAP5was the primary defect in thesemutant
cells, we identified the hamster PGAP5 gene, analyzed its cDNA
from the C9 and C19 mutant cells, and found that 75 bases
between positions 480 and 554 from the start codon were
deleted in both mutant cells (Figures S6 and S7A–S7C). The
region deleted in the mutant cells corresponds to exon 6 in the
human and mouse PGAP5 (NM_023075 for H. sapiens and
NM_172630 forMus musculus), suggesting that the mutant cells
have a defect in the exon-intron boundary of exon 6. We
analyzed the genomic PGAP5 and revealed a GA transition at
the donor splice site of intron 6 (gtgagt to gtgaat), which is known
to cause skipping of exon (Tavassoli et al., 1997), in C19 mutant
cells (Figures S7D and S7E). When the hamster PGAP5 cDNAs
were transfected into C19 cells, WT cDNA, but not the mutant
cDNA, restored the delayed transport of GPI-APs (data not
shown). Therefore, the defect in PGAP5 is the primary cause
for the phenotypes of the mutant cells.
PGAP5 Is Localized at the ER-Exit Site, ERGIC,
and cis-Golgi
We next examined the cellular localizations of PGAP5 in CHO
and normal rat kidney (NRK) cells. HA-tagged PGAP5 (HA-
Figure 2. ER-to-Golgi Transport of GPI-APs Is Selectively
Delayed in Mutant Cells
(A) Western blotting analysis of total DAF. Cell lysates of WT, C9,
and C19 cells were analyzed with an anti-DAF antibody under
nonreducing conditions to evaluate steady-state levels of ER
and mature forms. TfR, transferrin receptor for loading assess-
ment.
(B and C) Pulse-chase analysis of newly synthesized DAF. WT
and C19 mutant cells were pulse-labeled with [35S]methionine/
cysteine followed by chasing for the indicated times. DAF was
immunoprecipitated using monoclonal anti-DAF antibody, sepa-
rated by SDS-PAGE under reducing conditions, and analyzed
using a BAS analyzer. The asterisks indicate nonspecific bands.
The band intensities of the ER and mature forms of DAF were
quantified and plotted as the means ± standard deviation (SD)
from three independent experiments (C).
(D and E) Transport analysis of VFG-GPI from the ER to the Golgi.
VFG-GPI was expressed in WT and C19 cells at 40C for 24 hr,
followed by incubation at 32C for the indicated times in the pres-
ence of 100 mg/ml cycloheximide, and detected with an anti-GFP
antibody. The band intensities of unprocessed and processed
VFG-GPI were quantified and plotted as the means ± SD from
two independent experiments (E).
hPGAP5), which fully restored the mutant phenotypes
(Figure 3A), was constructed to investigate the locali-
zation. HA-hPGAP5 signals were detected strongly in
the perinuclear area and as dot-like structures more
dispersedly (Figure 3B, left panels). Signals of HA-
hPGAP5 were not colocalized with those of the ER
marker calnexin (CNX) (top panels). The signals in the
perinuclear area merged with those of the Golgi
marker GPP130 (bottom panels), whereas the majority of dot-
like signals of HA-hPGAP5 were colocalized with ER-Golgi inter-
mediate compartment (ERGIC)-53 and b-COP (third and fourth
sets of panels from top, respectively). Some of the dot-like
signals were colocalized with the ER-exit site marker Sec16
(second set of panels from top). ERGIC-53 and b-COP are local-
ized at the ERGIC and cis-Golgi (Klumperman et al., 1998). To
strengthen the point that PGAP5 is in the ERGIC, we incubated
cells in 5 mg/ml of brefeldin A to relocalize Golgi, but not ERGIC,
proteins to the ER (Lippincott-Schwartz et al., 1990). Under
these conditions, dot-like PGAP5-expressing structures re-
mained, supporting the ERGIC localization of PGAP5 (Fig-
ure 3C). Therefore, HA-hPGAP5 is distributed in the ER-exit
site, ERGIC, and cis-Golgi, although it should be noted that
HA-hPGAP5 may be expressed higher than endogenous
PGAP5 and had wider distribution than that of endogenous
PGAP5.
The ER retrieval signal KxKxx at the C terminus is conserved
among PGAP5 homologs from fish to primates except for
rodents (Figure S6). To check whether the ER retrieval signal is
functional, the two Lys residues of the signal were replaced
with Ala (K2A). The K2A protein localization at the dot-like struc-
tures was diminished (Figure 3D), suggesting that the C-terminal
KxKxx motif functions as an ER retrieval signal and that PGAP5
recycles between the ER and theGolgi. The ability of K2APGAP5
in restoring transport in C19 mutant cells was severely dimin-
ished as expected (Figure S8).Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc. 355
Figure 3. Expression Cloning of PGAP5 and Subcellular Localization of PGAP5 Protein
(A) Transfection ofPGAP5 restores the delayed transport of a reporter GPI-AP inmutant cells. Flow cytometric analyses of VFG-GPI transport to the cell surface at
45 min after a temperature shift from 40C to 32Cwere carried out in WT cells (top panel, shaded), mutant cells stably transfected with the empty vector (middle
panel, shaded), andmutant cells stably transfectedwith HA-tagged human PGAP5 (bottom panel, shaded). Red lines inmiddle and bottom panels, the level ofWT
cells; green line in bottom panel, the level of C19 cells with the empty vector.
(B) PGAP5 is localized at the ER-exit site, ERGIC, and cis-Golgi. NRK cells transiently transfected with HA-hPGAP5 were fixed, permeabilized with Triton X-100,
and stained with an anti-HA antibody (left panels) and antibodies against calnexin (CNX), Sec16, ERGIC-53, b-COP, andGPP130 (middle panels). Merged profiles
are shown in the right panels. Bars, 10 mm.
(C) Brefeldin A (BFA) treatment. C19 cells stably expressing HA-hPGAP5 pretreated with or without 5 mg/ml BFA for 30minwere fixed, permeabilized, and double-
labeled with anti-HA and anti-GPP130 antibodies. Bars, 10 mm.
(D) PGAP5 localized at dot-like structures is diminished by the K2A mutation. The localization of HA-hPGAP5 was observed in CHO cells stably transfected with
WT or K2A mutant PGAP5 (left panels). GPP130 was stained as a Golgi marker (middle panels). Merged profiles are shown in the right panels. Bars, 10 mm.356 Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc.
PGAP5 Is Associated with GPI-AP and p23
Since the transport of GPI-APs was specifically delayed in the
PGAP5mutant cells, we analyzed whether PGAP5 is associated
with GPI-APs. To confirm the association of PGAP5 with GPI-
APs, immunoprecipitation of HA-hPGAP5 was performed. As a
control, HA-tagged aldehyde dehydrogenase (ALDH) encoding
an ER protein was used (Figure 4A). We also included H158A,
an active site mutant of PGAP5 to see whether the active site
Figure 4. PGAP5 Associates with GPI-APs and
p23, and GPI-APs Accumulate in the ER under
PGAP5 Deficiency
(A) Immunoprecipitation of HA-hPGAP5 with GPI-APs and
p23. C19 mutant cells permanently harboring the empty
vector, HA-PGAP5, HA-H158A, or HA-ALDH were
cultured with doxycycline at 40C for 24 hr to induce
VFG-GPI expression and its accumulation in the ER. The
cells were then incubated at 32C for 15 min to initiate
VFG-GPI transport. After cell lysis with 1% digitonin, HA-
tagged proteins were precipitated with anti-HA agarose
and coprecipitated proteins, VFG-GPI, p23, ERGIC53,
and GPP130, were analyzed by western blotting. VFG-
GPI was detected with an anti-Flag antibody. One-fortieth
amounts of total samples and entire immunoprecipitates
were used for analysis. Relative amounts of HA-hPGAP5
and HA-ALDH seemed reversed in total lanes and IP lanes
(top two panels) likely due to less efficient immunoprecip-
itation of HA-ALDH and broader bands of HA-hPGAP5
bearing heterogeneous N-glycans.
(B) Plasma membrane localization in WT and HA-PGAP5-
carrying C19 cells and ER localization in C19 cells of
EGFP-F-CD59. Cells transiently expressing EGFP-F-
CD59 were fixed and observed with confocal microscopy.
Bars, 10 mm.
(C and D) GPI-APs accumulates in the ER in C19 mutant
cells. C19 cells stably expressing mRFP-KDEL (C) or
Sec13-mStrawberry (D) were transfected with EGFP-F-
CD59, fixed, and observed with confocal microscopy.
Arrowheads indicate the ER-exit sites stained with
Sec13-mStrawberry. Bars, 10 mm.
is important for association. VFG-GPI was
weakly, but specifically, coprecipitated with
PGAP5 (Figure 4A, third panel from top).
Surprisingly, PGAP5 was also bound to p23
(fourth panel from top). The p24 family mem-
bers, including p23, are known to be required
for efficient transport of GPI-APs from the ER
in both yeasts and mammalian cells (Schimmol-
ler et al., 1995; Takida et al., 2008). On the
contrary, the transmembrane proteins ERGIC-
53 and GPP130 were not coprecipitated with
PGAP5 (bottom two panels). To examine
whether the association of PGAP5 with VFG-
GPI depends on the GPI anchor, we performed
immunoprecipitation experiments with a con-
struct that was similar but involved the trans-
membrane protein FVG-TM. The C19 mutant
cells shown in Figure 4A were transiently trans-
fected with FVG-TM and an immunoprecipita-
tion analysis was performed similarly. FVG-TM
was not coprecipitated with PGAP5 (Figure S9), suggesting
that PGAP5 is associated with VFG-GPI via the GPI portion.
Accumulation of GPI-AP in the ER but Not
the ER-Exit Site in the Absence of PGAP5
Because PGAP5 partly exists in the ER-exit site (Figure 3B) and
is associated with GPI-APs (Figure 4A) and because a defect
in PGAP5 caused delayed ER-to-Golgi transport of GPI-APsCell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc. 357
(Figure 2), we next analyzed localization of GPI-APs (EGFP-F-
CD59, a fusion protein of EGFP and CD59) in WT, C19, and
HA-PGAP5-carrying C19 cells. Whereas WT and HA-PGAP5-
carrying C19 cells had strong cell-surface expression of EGFP-
F-CD59, C19 cells showed the ER expression of EGFP-F-
CD59 in addition to the cell surface (Figure 4B). The expression
pattern of EGFP-F-CD59 in C19 cells was nicely overlapped
with that of the ER marker mRFP-KDEL (Figure 4C). The expres-
sion pattern of EGFP-F-CD59, however, was not coincided with
that of the ER-exit site marker Sec13. The red dots representing
mStrawberry-labeled Sec13 (Nagaya et al., 2008) were mainly
seen in the areas where the green color of EGFP-F-CD59 was
dull (Figure 4D). It is, therefore, suggested that GPI-AP is not
accumulated in the ER-exit site but rather that GPI-AP is not
found clearly in the ER-exit site in the absence of PGAP5. To
confirm that GPI-AP is not accumulated in the ER-exit site in
C19 cells, we monitored the transport of VFG-GPI after temper-
ature block and release. In WT cells, VFG-GPI that accumulated
in the ER at time zero appeared in the Golgi at 10 min and nearly
completely moved to the Golgi by 20 min (Figure S10). In C19
cells, the appearance of VFG-GPI in the Golgi was slow and
the ER pattern remained even at 30 min. However, a dot-like
pattern was not seen during the monitoring period, supporting
that it has a defect in the GPI-APs sorting to the ER-exit site
for the effective transport when PGAP5 is not functioning.
Structural Analysis of the GPI Anchor
The GPI glycan contains several phosphodiester bonds. Since
PGAP5 possesses a phosphoesterase motif, we investigated
whether the GPI glycan structure is changed in the mutant cells.
His-Flag-GST-Flag-tagged CD59 (HFGF-CD59) was perma-
nently expressed in WT, C19, and HA-PGAP5-carrying C19
cells, isolated from their cell surface and analyzed by liquid chro-
matography electrospray ionization tandem mass spectrometry
(LC-ESI-MS/MS) after trypsin digestion. The molecular ions of
the C-terminal peptide bearing GPI were screened by the pres-
ence of GPI-specific collision fragments ofm/z 422.1+ (glucosa-
minyl-inositol-phosphate, GlcN-Ino-P) and 447.1+ (ethanol-
amine-phosphate-mannosyl-glucosamine, EtNP-Man-GlcN) in
the second MS. As reported previously (Taguchi et al., 1994; Ta-
shima et al., 2006), most of the peptides bearing GPI consisted
of peptide-EtNP-Man-Man-(EtNP)Man-GlcN-Ino-P in WT cells
(Figure 5A). In contrast, the majority of the GPI structures in the
mutant cells had an additional side-chain EtNP attached to
Man2 (Figure 5B). In the revertant cells permanently expressing
HA-tagged PGAP5, the structures had reverted to those of the
WT cells (Figure 5C). These results indicate that PGAP5 is
required for removal of a side-chain EtNP from Man2.
Enzymatic Activity of PGAP5
To determine whether PGAP5 is the enzyme, we expressed
His6-Flag-tagged PGAP5 (HF-PGAP5) in CHO cells, purified
it, and established an in vitro enzyme assay. HF-PGAP5 was
sequentially purified using a Ni column and anti-Flag beads
and analyzed by silver staining. A prominent silver-stained
band that migrated with a molecular mass of 50 kDa was con-
firmed to be HF-PGAP5 by western blot analysis with an anti-
Flag antibody (Figure 6A). Although the natural substrate for358 Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc.PGAP5 was considered to be protein-linked GPI, it seemed
difficult to measure its structural change and to prepare it in a
sufficient amount. Therefore, we first measured the phosphoes-
terase activity using several artificial substrates, including
p-nitrophenyl phosphate and monofluorophosphate. However,
HF-PGAP5 did not recognize these molecules as substrates
(data not shown). We subsequently used the GPI intermediate
H8 as a substrate. H8 has structure EtNP-Man-(EtNP)Man-
(EtNP)Man-GlcN-(acyl)PI, which is a complete precursor just
before GPI attachment (Hirose et al., 1992). When [14C]Man-
labeled H8was incubated with HF-PGAP5, it was efficiently con-
verted into H7 lacking the side-chain EtNP on Man2 (Figure 6B),
indicating that PGAP5 is the enzyme involved in the removal of
EtNP fromMan2 of GPI. The PGAP5 activity was time dependent
and the reaction was linear up to 45 min under the conditions
used (Figures 6C and 6D). The enzyme exhibited optimal activity
at pH 7.0–7.5 (Figures 6E and 6F). We then examined the metal
dependency of PGAP5. The yeast homolog of PGAP5, CDC1, is
linked toMn2+ homeostasis (Paidhungat andGarrett, 1998) since
cdc1 mutant cells are rescued by Mn2+ supplementation and
hypersensitive to the divalent cation chelator EGTA. As ex-
pected, Mn2+ was required for the PGAP5 activity. Zn2+ partially
activated the PGAP5 activity. The PGAP5 activity was abolished
by addition of EDTA to the reaction mixture (Figures 6G and 6H).
PGAP5 Enzymatic Activity Is Essential
for Efficient Transport of GPI-APs
PGAP5 has a phosphoesterase motif (Figure 7A), which is con-
served among dimetal-containing phosphoesterase proteins,
including 50-nucleotidases, sphingomyelinases, and purple acid
phosphatases (PAPs). We attempted to build a 3D structural
model of the lumenal domainof humanPGAP5.Usinga fully auto-
mated homology modeling system (FAMS) that incorporates
query sequence information in combination with structural infor-
mation (Ogata and Umeyama, 2000), we successfully identified
pig PAP as a remote homolog of human PGAP5. The model of
the PGAP5 lumenal domainwas then built based on the 3D struc-
ture of pigPAP (PDBcode: 1UTE) (Figures 7Band7C). Themetal-
coordinating residues found in the dimetal-containing phos-
phoesterase family are entirely conserved in PGAP5 homologs
from yeast to humans (Figure S6). For human PGAP5, the resi-
dues are Asp77, His79, Asp119, Asn157, His158, His249,
His303, and His305, whose side chains are structurally equiva-
lent to those of Asp14, His16, Asp52, Asn91, His92, His186,
His221, and His223 in pig PAP, respectively. Since PGAP5 was
found to be a Mn2+-dependent enzyme, the dimetal center was
modeled with twoMn2+ ions. An EtNPwas arranged on the puta-
tive catalytic site based on the phosphate in the PAP-phosphate
complex (Figures 7D and 7E). The residues required for themetal
binding and phosphoesterase activity were replaced with Ala or
Asn. The mutant PGAP5 constructs were stably transfected
into the C19 mutant cells, and the GPI-AP transport assay was
performed. Transfection of the PGAP5 cDNA with mutation in
the putative active site did not restore the delayed transport
in the C19 cells, whereas transfection of WT PGAP5 did restore
the transport (Figure 7F). Taken together, these results suggest
that the enzymatic activity of PGAP5 is essential for the efficient
transport of GPI-APs.
Figure 5. Structural Analysis of the GPI
Glycan
(A and B) HFGF-CD59 was released from the cell
surface of WT or C19 mutant cells by PI-PLC,
purified, digested with trypsin, and analyzed by
LC-ESI-MS/MS. The MS/MS spectra of the
parental ion of m/z 12672+ from the WT cells (A)
and m/z 13282+ from the C19 cells (B) are shown.
Top: the determined structures and absolute
masses. Bottom: the MS/MS fragments. The
b-series fragments are indicated by green arrows,
and the terminal and internal fragments of the GPI
structure are indicated by red and black arrows,
respectively. The orange arrows indicate m/z
422, a GPI-specific fragment ion treated with PI-
PLC.
(C) Ratios of GPI structures containing a side-
chain EtNP on Man2 to those lacking a side-chain
EtNP on Man2 in WT cells, C19 mutant cells, and
C19 cells stably transfected with HA-hPGAP5.
The ratios were calculated from the peak area of
each species of parental ion. These structures
contain GPI peptides bearing N-acetylhexos-
amine attached to Man1 as reported previously
(Tashima et al., 2006).Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc. 359
Figure 6. PGAP5 Is Directly Required for Removal of EtNP from Man2 of GPI Anchors
(A) Purification of HF-PGAP5. HF-PGAP5 affinity-purified from stably transfected CHO cells was subjected to SDS-PAGE (lane 1: 10 ml sample; lane 2: 20 ml),
followed by silver staining. M, molecular size markers; WB, western blotting with an anti-Flag antibody.
(B) PGAP5 removes a side-chain EtNP from Man2. Purified HF-PGAP5 or buffer was incubated with [14C]Man-labeled H8, which consists of (EtNP)Man-
(EtNP)Man-(EtNP)Man-GlcN-(acyl)PI, in a buffer comprising 50 mM MES/HEPES (pH 6.5), 100 mM NaCl, 0.1 mM MnCl2, 0.1 mM MgCl2, 0.1 mM CaCl2, and
0.1% Triton X-100. After a 12 hr incubation at 37C, the lipids were analyzed by TLC using a solvent system of chloroform/methanol/water (10:10:3).
[14C]Man-GPI from GAA1 knockout cells labeled with [14C]Man were used as marker for the GPI intermediates. H6 consists of Man-Man-(EtNP)Man-GlcN-
(acyl)PI. H7 consists of (EtNP)Man-Man-(EtNP)Man-GlcN-(acyl)PI.
(C–H) The time (C and D), pH (E and F), and metal (G and H) dependencies of PGAP5 activity were evaluated. (F and H) The percentage of conversion of H8 were
quantified and indicated as the means ± SD from three independent experiments.DISCUSSION
For the efficient trafficking to the Golgi, most secretory proteins
are sorted to and enriched in the ER-exit site. Cargo receptors360 Cell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc.play important roles in the enrichment of the cargos. For
example, soluble cargos, such as pro-a factor and carboxy-
peptidase Y, are sorted and transported efficiently by their
cargo receptor Erv29p in yeasts (Belden and Barlowe, 2001b).
ERGIC-53, a lectin-type cargo receptor, recognizes properly
processedN-linked glycans and promotes enrichment of several
glycoproteins in transport vesicles (Appenzeller et al., 1999;
Hauri et al., 2000). Although sorting mechanisms for GPI-APs
to the ER-exit site is poorly defined, it is postulated that the
GPI moiety is recognized by cargo receptors and acts as a signal
for sorting of GPI-APs (Mayor and Riezman, 2004). In the present
study, we established mutant cells that were selectively defec-
tive in transport of GPI-APs from the ER and identified the
gene PGAP5 as being responsible for the defect. Strikingly,
PGAP5 is an enzyme that removes the side-chain EtNP on
Man2 from GPI anchors, suggesting that the processing of the
GPI glycan mediated by PGAP5 is critical for efficient GPI-AP
transport from the ER to the Golgi (Figure 7G). These findings
demonstrate that the GPI glycan functions as an ER-exit signal
and regulates GPI-AP transport in the early secretory pathway.
It is most likely that EtNP cleavage by PGAP5 occurs in the ER
rather than in the ERGIC or the Golgi because the defect in
PGAP5 results in the accumulation of GPI-APs in the ER and their
transport delay from the ER, and the PGAP5 enzymatic activity
was optimal at pH 7.0–7.5, which is consistent with the pH in
the ER. Furthermore, PGAP5 was partially localized at the ER-
exit site, although a significant fraction of PGAP5 was also found
in the ERGIC and the Golgi. We suggest that PGAP5 is recycled
between the ER and the Golgi, but it remains to be determined
whether transport of PGAP5 to the Golgi is required for its func-
tion or not and how PGAP5 is transported from the ER. Enzy-
matic activity of PGAP5 was found to be critical for cargo sorting
given that the active site-dead PGAP5 mutant could not restore
the delayed transport of GPI-APs in the C19 mutant cells. There-
fore, it seems that the side-chain EtNP behaves like a molecular
signature for entry of GPI-APs into the ER-exit site and sub-
sequent cleavage of the EtNP is essential for the transport
(Figure 7G). PGAP5may recruit or trap GPI-APs and concentrate
them at the ER-exit site.
Interestingly, PGAP5 was associated with p23, a p24 family
protein. Members of the p24 family have been reported as puta-
tive cargo receptors for GPI-APs in yeasts (Muniz et al., 2000).
The p24 proteins play key roles in maintaining the fidelity of
GPI-AP vesicle transport from the ER, but these are unlikely to
be the only functions of p24 complexes (Kaiser, 2000). emp24
and erv25 mutants showed defective transport of invertase, a
soluble secreted protein (Schimmoller et al., 1995). Mutations
of several yeast p24 genes resulted in secretion of BiP/Kar2p
(Belden and Barlowe, 2001a). These results suggest that p24
proteins may act as cargo receptors together with specific part-
ners that recognize the cargos. We speculate that PGAP5
recruits and sorts GPI-APs together with p24 heteromeric com-
plexes to the ER-exit site. Another possibility is that p23 interac-
tion with PGAP5 may occur during recycling of PGAP5 between
the ER and the Golgi because p23 is also involved in retrograde
transport of vesicles from the Golgi to the ER. These possibilities
will be addressed in further studies.
Several previous studies in yeasts support our idea that PGAP5
is involved in recruitment and sorting of GPI-APs. The yeast
genome contains two PGAP5 homologs, CDC1 and TED1.
TED1 is thought to act together with EMP24 and ERV25 in the
ER exit (Haass et al., 2007). TED1 was found during screeningfor genes necessary for cell-surface expression of a potassium
channel, Kir. In this screening, BST1, EMP24, and ERV25 were
also isolated. BST1 encodes a yeast homolog of PGAP1, which
is GPI inositol deacylase (Fujita et al., 2006b; Tanaka et al.,
2004). From the genetic analysis, it is predicted that Bst1p and
Ted1p function in the Emp24p/Erv25p-dependent trafficking
pathways (Haass et al., 2007). Furthermore, ted1 mutant cells
show delayed transport of a GPI-AP, Gas1p, from the ER, sug-
gesting that GPI-APs processed by Ted1p/PGAP5 become
associated with p24 family-dependent pathways. Unless the
second EtNP on GPI is removed by PGAP5, GPI-APs may not
become concentrated into p24-dependent vesicles.
The other yeast homolog, CDC1, was originally identified in a
screen for cell division cycle defects (Hartwell et al., 1970) and
encodes an ER-localized protein implicated in actin polarization
and the inheritance of late Golgi elements (Losev et al., 2008;
Rossanese et al., 2001), although its biochemical functions
remain unknown. cdc1 mutant cells are rescued by addition of
Mn2+, consistent with the requirement of Mn2+ for PGAP5 enzy-
matic activity. The temperature sensitivity of cdc1mutant cells is
suppressed by additional mutations in COS16/PER1 (Paidhun-
gat and Garrett, 1998) and GUP1 (Losev et al., 2008). Both
Per1p and Gup1p are involved in lipid remodeling of GPI-APs
in yeast (Bosson et al., 2006; Fujita et al., 2006a). Since the addi-
tional mutations in PER1 or GUP1 suppress the phenotypes in
cdc1 mutant cells, Per1p and Gup1p function at the epistatic
position of Cdc1p. In yeasts, lipid remodeling of GPI-APs is
carried out before their exit from the ER (Fujita and Jigami,
2008), further supporting that Cdc1p/PGAP5 acts at the final
step for sorting of GPI-APs to the ER-exit site. It is not clear
why two PGAP5 homologs exist in yeast. In yeast, however,
two types of lipid remodeling of GPI-APs take place in the ER, re-
sulting in GPI-APs containing either ceramide-based lipid or di-
acylglycerol-based lipid containing very long fatty acid at the
sn-2 position (Sipos et al., 1997). One possibility is that two
PGAP5 homologs are required for the recognition and cleavage
of the side-chain EtNP from yeast GPI-APs containing different
lipid moieties.
In the GPI biosynthetic pathway, EtNP is transferred to Man2
of GPI intermediate H7 by an ethanolamine-phosphotransferase
PIG-G/GPI7 and PIG-F to generate H8, but the physiological
function had not been understood. H7 was thought to be the
major substrate for protein anchoring because the GPI struc-
tures of GPI-APs on the cell surface mostly lack the second
side-chain EtNP, despite the existence of H8 as a GPI precursor.
In the present study, we found that more than 80% of HFGF-
CD59 retained the side-chain EtNP on Man2 in the C19 mutant
cells, indicating that H8 is the major substrate for attachment
to proteins. The side-chain EtNP on Man2 is then eliminated by
PGAP5 after attachment to proteins, which is crucial for the effi-
cient transport of GPI-APs from the ER. Therefore, the side-chain
EtNP is a transient modification of Man2 present only in the final
GPI precursor and the nascent GPI-APs and may act as a signal
to concentrate GPI-APs to the ER-exit site (Figure 7G). It is very
likely that ER-to-Golgi transport of GPI-APs is delayed like in
PGAP5-defective cells, when the side-chain EtNP on Man2 is
not attached due to defective PIG-G/GPI7. In gpi7-defective
yeast, ER-to-Golgi transport of GPI-APs is in fact delayedCell 139, 352–365, October 16, 2009 ª2009 Elsevier Inc. 361
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(Benachour et al., 1999). It is, however, unclear whether this is
a direct effect of a lack of the side-chain attachment or if GPI-
AP transport is indirectly affected by a defective lipid remodeling
to ceramide-type GPI known to be caused by GPI7 deficiency.
Homologs of PGAP5 are found in the genome database of a
wide variety of organisms, suggesting that attachment by PIG-
F/GPI7 and detachment by PGAP5 of the side-chain EtNP on
Man2 is widely used in various organisms for efficient transport
of GPI-APs. However, there is no PGAP5 homolog in trypano-
somes that abundantly generates GPI-APs. Consistent with
this, T. brucei does not appear to have a GPI7 homolog, indi-
cating that efficient transport of GPI-APs is achieved in trypano-
somes by means of other mechanisms.
There is a report that free GPI including H8 is found in the
plasma membrane, indicating that free H8 can be transported
from the ER to the plasma membrane (Baumann et al., 2000).
If a similar mechanism applies to ER export of free GPI, transport
of H8 must be slower than that of H7. However, transport of free
GPI might be mediated by a route different from that of GPI-APs.
Althoughwe have clarified one important role of theGPI glycan
in the transport of GPI-APs at the cellular level, whether such
a GPI glycan-dependent regulation of a secretory pathway has
an impact on the physiology of animals remains unknown. These
questions should be addressable now that PGAP5 and its func-
tions have been identified.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Data.
Establishment of C9 and C19 Mutant Cells
and Expression Cloning of PGAP5
FF8 cells were treated with 1 mg/ml N-methyl-N’-nitro-N-nitrosoguanidine for
20 hr and cultured for 1 week. Subsequently, cells with delayed surface
expression of the reporter protein were enriched by several rounds of cell sort-
ing using a FACSAria (BD Bioscience). The population obtained by this sorting
procedure was subjected to limiting dilution, and two clones were selected
and designated the M85-C9 and M85-C19 cell lines (referred to as C9 and
C19 cells, respectively).
To use a retrovirus system for expression cloning of the responsible gene,
C19 cells transiently expressing mouse CAT1, a receptor for ecotropic retro-
viruses, were created by transfection of pME-mCAT1. The cells were theninfected with a human brain retroviral cDNA library (Clontech). After transport
assays, the cells were stained for Flag epitope, and cells expressing high levels
of the reporter protein were enriched 3-fold by the FACSAria. Several cell lines
that exhibited normal transport of the reporter protein were obtained by
limiting dilution from the enriched cell pool. Genomic DNAs were extracted
from each cell line, and retrovirus-derived cDNAs integrated into the genome
were amplified by PCR.
Transport Assay of Reporter Proteins
Cells derived from FF8 cells were cultured in complete medium containing
1 mg/ml doxycycline at 40C for 24 hr, quickly harvested with trypsin-EDTA
solution (Sigma), and incubated in complete medium at 32C for the required
times. The cells were stained with an M2 anti-Flag antibody and PE-conju-
gated goat anti-mouse IgG and analyzed using a FACSCalibur (BD Biosci-
ences) or the FACSAria. In some cases, cells were transiently transfected
with expression plasmids for reporter proteins using Lipofectamine 2000. At
10–12 hr after transfection, the temperature was shifted to 40C and the cells
were cultured for a further 24 hr, followed by incubation at 32C for the required
times. In addition to the first gating (FSC and SSC), a second gating to select
cells expressing the same amount of reporter protein (brightness of EGFP
in FL1) was performed for analysis using the CellQuest Pro software (BD
Bioscience).
In Vitro Assay for PGAP5 Enzymatic Activity
[14C]H8 was dried and resuspended by vortexing and sonication in reaction
buffer comprising 50 mM MES/HEPES (pH 5–8), 100 mM NaCl, 0.1% Triton
X-100, 0.1 mM MnCl2, 0.1 mM MgCl2, 0.1 mM ZnCl2, and 0.1 mM CaCl2.
For measurements of pH or metal dependency, the compositions of the reac-
tion buffer were changed properly. The reactions were started by addition of
purified HF-PGAP5, followed by incubation at 37C for 30 min. The reactions
were stopped with addition of water-saturated 1-butanol and kept on ice. After
butanol partitioning and drying, the samples were analyzed by TLC with
a solvent system of chloroform/methanol/water (10:10:3).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
ten figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)01114-3.
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